Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7288638 Fully human antibodies against human 4-1BB

Patent 7288638 was granted and assigned to Bristol-Myers Squibb on October, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
Date Filed
October 8, 2004
Date of Patent
October 30, 2007
Patent Application Number
10961567
Patent Citations Received
‌
US Patent 12104172 Processes for generating TIL products enriched for tumor antigen-specific t-cells
0
‌
US Patent 11932680 CD8A-binding fibronectin type III domains
0
‌
US Patent 11976125 B cell maturation antigen binding proteins
0
‌
US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment
0
‌
US Patent 11999800 Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer
0
‌
US Patent 12006347 Superagonists and antagonists of interleukin-2
0
‌
US Patent 12024718 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
‌
US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site
0
‌
US Patent 11713446 Processes for generating TIL products enriched for tumor antigen-specific T-cells
0
•••
Patent Inventor Names
Edward L. Halk
0
Subinay Ganguly
0
Maria Jure-Kunkel
0
Marc Santoro
0
Laura J. Hefta
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7288638
Patent Primary Examiner
‌
Phillip Gambel

Find more entities like US Patent 7288638 Fully human antibodies against human 4-1BB

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo